Tumor-infiltrating B cells and T cells: Working together to promote patient survival

OncoImmunology

Volumn 1, Issue 9, 2012, Pages 1623-1625

  Nielsen, Julie S ^a,b   Nelson, Brad H ^a,b,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Antigen presenting cells; B cells; Ovarian cancer; T cells; Tumor infiltrating lymphocytes

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; MESSENGER RNA;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; BREAST CANCER; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; LUNG CANCER; MEMORY CELL; NOTE; OVARY CANCER; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CANCER;

EID: 84883244497     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.21650     Document Type: Note

References (10)

1. Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010; 29:1093- 102; PMID:19946335; http://dx.doi.org/10.1038/onc.2009.416.
2. Nelson BH. CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol 2010; 185:4977-82; PMID:20962266; http://dx.doi.org/10.4049/jimmunol.1001323.
3. Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH, et al. CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer. Clin Cancer Res 2012; 18:3281-92; PMID:22553348; http://dx.doi.org/10.1158/1078-0432.CCR-12-0234.
4. Milne K, Köbel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, et al. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One 2009; 4:e6412; PMID:19641607; http://dx.doi.org/10.1371/journal.pone.0006412.
5. Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, et al. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer 2003; 104:73-84; PMID:12532422; http://dx.doi.org/10.1002/ijc.10900.
6. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008; 223:284-99; PMID:18613843; http://dx.doi.org/10.1111/j.1600-065X.2008.00646.x.
7. Martin F, Chan AC. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006; 24:467-96; PMID:16551256; http://dx.doi.org/10.1146/annurev.immunol.24.021605.090517.
8. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity. Semin Immunol 2008; 20:26-42; PMID:18243731; http://dx.doi.org/10.1016/j.smim.2007.12.004.
9. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol 2001; 167:4710-8; PMID:11591802.
10. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000; 1:475-82; PMID:11101868; http://dx.doi.org/10.1038/82717.